Portfolio Size | |
---|---|
Rebalancing Frequency | |
Minimum Annual Investment | |
Subscription Tenure | |
Risk Tolerance | |
Stocks Group Title | |
ETFs Composition Percentage | |
Subscription Plan Fee |
5 Equity Scripts Long Term Growth Model Portfolio | Industry – Pharmaceuticals | Rebalancing Monthly | Risk Tolerance needed is above 60% | ETFs Composition is 0% | 12 Months Subscription Plan
You cannot purchase the subscription product again, as you have already purchased one subscription product
Telegram Bot Command for @ShubhaangBot : /phrm_5_390000_n_0
Download Link : Factsheet and Research Report (Pharma_5_m_12_n_0)
Minimum Annual Investment : ₹ 3,90,000
Investment Horizon : Long Term – 5 or more years.
Risk Tolerance : Risk Tolerance needed is above 60%
Portfolio Size : 5 Equity Scripts
ETFs Composition Percentage : ETFs Composition is 0%
Rebalancing Frequency : Rebalancing Monthly
Subscription Tenure : 12 Months Subscription Plan
Stock Group Title : Industry – Pharmaceuticals
Reviews
There are no reviews yet.